Allergan

Allergan

Verified
Is a global pharmaceutical company

Launch date
Employees
Market cap
$63.7b
Net debt
($10.1m)
Firm valuation
$63.6b (Public information from 2022)
Parsippany-Troy Hills New Jersey (HQ)
Deals in current and previous year:

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-14.5b14.3b14.6b13.8b14.4b14.7b
% growth--(1 %)2 %(5 %)4 %2 %
EV / revenue-3.4x2.9x3.9x4.2x4.0x3.9x
EV / EBITDA-6957.0x5807.0x8339.0x---
R&D budget2.7b1.7b2.0b1.6b---
R&D % of revenue-12 %14 %11 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/A-
Not yet verified
N/AN/AIPO
*
$63.0bAcquisition
Total Funding-

Recent News about Allergan

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Allergan

Edit
Lysosomal Therapeutics
ACQUISITION by Allergan Jan 2017
RetroSense Therapeutics
ACQUISITION by Allergan Sep 2016
Chase Pharmaceuticals
ACQUISITION by Allergan Nov 2016
Naurex
ACQUISITION by Allergan Jul 2015
Kythera Biopharmaceuticals
ACQUISITION by Allergan Jun 2015
LifeCell
ACQUISITION by Allergan Dec 2016
ANTERIOS
ACQUISITION by Allergan Jan 2016
Oculeve
ACQUISITION by Allergan Jul 2015
Serica Technologies
ACQUISITION by Allergan Feb 2010
Vitae Pharmaceuticals
ACQUISITION by Allergan Sep 2016
View 11 more